Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...

Hims & Hers Health (HIMS) lays off 4% of its workforce as the company adjusted its strategy amid FDA scrutiny on copycat ...

Hims Hers Health Inc (NYSE:HIMS), a telehealth firm known for offering consumer-focused digital healthcare, is reducing its headcount by more than 4% as part of a pivot in its business strategy, ...

It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able ...

We recently published a list of Investors Rushed Into These 10 Stocks Today. In this article, we are going to take a look at ...

Japan’s foray into regenerative medicine takes on added importance for a nation wrestling with age, stagnation, and its place ...

The court’s intervention comes at a crucial time as Novo Nordisk gears up for the rollout of Wegovy, amid rising global ...

HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...

Taiwan Semiconductor Manufacturing Company (TSM), or TSMC for short, the world’s numero uno pure-play semiconductor foundry, ...